Cargando…
CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common primary liver malignancies worldwide. The long-term prognosis for HCC remains extremely poor, with drug resistance being the major underlying cause of recurrence and mortality. The lncRNA colorectal neoplasia differentially express...
Autores principales: | Liu, Yu-Chin, Lin, Yang-Hsiang, Chi, Hsiang-Cheng, Huang, Po-Shuan, Liao, Chia-Jung, Liou, Yu-Syuan, Lin, Chiao-Chun, Yu, Chia-Jung, Yeh, Chau-Ting, Huang, Ya-Hui, Lin, Kwang-Huei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400329/ https://www.ncbi.nlm.nih.gov/pubmed/35999564 http://dx.doi.org/10.1186/s13148-022-01326-3 |
Ejemplares similares
-
Thyroid hormone inhibits growth of hepatoma cells through induction of miR-214
por: Huang, Po-Shuan, et al.
Publicado: (2017) -
Roles of Thyroid Hormone-Associated microRNAs Affecting Oxidative Stress in Human Hepatocellular Carcinoma
por: Huang, Po-Shuan, et al.
Publicado: (2019) -
Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease
por: Liao, Chia-Jung, et al.
Publicado: (2022) -
Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2023) -
Dysregulated FAM215A Stimulates LAMP2 Expression to Confer Drug-Resistant and Malignant in Human Liver Cancer
por: Huang, Po-Shuan, et al.
Publicado: (2020)